Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.

Borrelli F, Izzo AA.

AAPS J. 2009 Dec;11(4):710-27. doi: 10.1208/s12248-009-9146-8. Epub 2009 Oct 27. Review.

2.

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

Izzo AA.

Int J Clin Pharmacol Ther. 2004 Mar;42(3):139-48. Review.

PMID:
15049433
3.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
4.

Drug interactions with St John's wort : mechanisms and clinical implications.

Mannel M.

Drug Saf. 2004;27(11):773-97. Review.

PMID:
15350151
5.

The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).

Markowitz JS, DeVane CL.

Psychopharmacol Bull. 2001 Winter;35(1):53-64. Review.

PMID:
12397870
6.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Barnes J, Anderson LA, Phillipson JD.

J Pharm Pharmacol. 2001 May;53(5):583-600. Review.

PMID:
11370698
7.

Clinical drugs that interact with St. John's wort and implication in drug development.

Di YM, Li CG, Xue CC, Zhou SF.

Curr Pharm Des. 2008;14(17):1723-42. Review.

PMID:
18673195
8.

An update on clinical drug interactions with the herbal antidepressant St. John's wort.

Zhou SF, Lai X.

Curr Drug Metab. 2008 Jun;9(5):394-409. Review.

PMID:
18537576
9.

[St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].

Schempp CM, Müller KA, Winghofer B, Schöpf E, Simon JC.

Hautarzt. 2002 May;53(5):316-21. Review. German.

PMID:
12063742
10.

Potential for interaction of kava and St. John's wort with drugs.

Singh YN.

J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. Review.

PMID:
16005588
11.

Mechanism of action of St John's wort in depression : what is known?

Butterweck V.

CNS Drugs. 2003;17(8):539-62. Review.

PMID:
12775192
12.

About the cover: St. John's wort.

[No authors listed]

J Soc Integr Oncol. 2006 Winter;4(1):52-5. Review.

PMID:
16737673
13.

Hyperforin in St. John's wort drug interactions.

Madabushi R, Frank B, Drewelow B, Derendorf H, Butterweck V.

Eur J Clin Pharmacol. 2006 Mar;62(3):225-33. Epub 2006 Feb 14. Review.

PMID:
16477470
14.

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.

Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P.

Br J Clin Pharmacol. 2002 Oct;54(4):349-56. Review.

15.

St. John's wort: a new alternative for depression?

Josey ES, Tackett RL.

Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.

PMID:
10190758
16.

Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.

Galeotti N.

J Ethnopharmacol. 2017 Mar 22;200:136-146. doi: 10.1016/j.jep.2017.02.016. Epub 2017 Feb 12. Review.

PMID:
28216196
17.

St. John's wort and depression: efficacy, safety and tolerability-an update.

Bilia AR, Gallori S, Vincieri FF.

Life Sci. 2002 May 17;70(26):3077-96. Review.

PMID:
12008092
18.

[Phytotherapy threats with emphasis on St. John's wort medicines].

Sienkiewicz J, Czarnik-Matusewicz H, Wiela-Hojeńska A.

Pol Merkur Lekarski. 2013 Nov;35(209):309-12. Review. Polish.

PMID:
24575655
19.

St John's wort (Hypericum perforatum) in major depression.

Shelton RC.

J Clin Psychiatry. 2009;70 Suppl 5:23-7. doi: 10.4088/JCP.8157su1c.05. Review.

20.

Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.

Russo E, Scicchitano F, Whalley BJ, Mazzitello C, Ciriaco M, Esposito S, Patanè M, Upton R, Pugliese M, Chimirri S, Mammì M, Palleria C, De Sarro G.

Phytother Res. 2014 May;28(5):643-55. doi: 10.1002/ptr.5050. Epub 2013 Jul 30. Review.

PMID:
23897801

Supplemental Content

Support Center